Literature DB >> 31503385

Aggregation of zinc-free p53 is inhibited by Hsp90 but not other chaperones.

Huiwen Wu1, H Jane Dyson.   

Abstract

The structured DNA-binding domain (DBD) of p53 is a well-known client protein of the chaperone Hsp90. The p53 DBD contains a single zinc ion, coordinated by the side chains of Cys176, His179, Cys238, and Cys242; zinc coordination plays a structural role to stabilize the DBD and is required for its DNA binding. The ambiguous nature of the p53-Hsp90 interaction, together with the stabilizing role of the zinc in the structure of the DBD, prompted us to examine the interaction of Hsp90 with zinc-free p53 DBD. NMR spectroscopy and native gel electrophoresis did not show any apparent preference for the interaction of the destabilized zinc-free form of p53 DBD with Hsp90. Intriguingly, however, at lower protein concentrations, closer to physiological concentrations, the addition of Hsp90, but not other chaperones such as Hsp70, Hsp40, p23, and HOP, appears to slow or prevent the aggregation of zinc-free p53 DBD. This result suggests that part of the function of the Hsp90-p53 interaction in the cell may be to stabilize the apoprotein in the absence of zinc.
© 2019 The Protein Society.

Entities:  

Keywords:  NMR; aggregation; chaperone-client interaction; holdase; native gel electrophoresis

Mesh:

Substances:

Year:  2019        PMID: 31503385      PMCID: PMC6798128          DOI: 10.1002/pro.3726

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  24 in total

1.  Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.

Authors:  James S Butler; Stewart N Loh
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

2.  Native agarose gel electrophoresis of multiprotein complexes.

Authors:  Rosalind Kim
Journal:  Cold Spring Harb Protoc       Date:  2011-07-01

3.  Cooperative action of Hsp70, Hsp90, and DnaJ proteins in protein renaturation.

Authors:  R J Schumacher; W J Hansen; B C Freeman; E Alnemri; G Litwack; D O Toft
Journal:  Biochemistry       Date:  1996-11-26       Impact factor: 3.162

Review 4.  The HSP90 chaperone machinery.

Authors:  Florian H Schopf; Maximilian M Biebl; Johannes Buchner
Journal:  Nat Rev Mol Cell Biol       Date:  2017-04-21       Impact factor: 94.444

5.  Modulation of the Hsp90 chaperone cycle by a stringent client protein.

Authors:  Oliver Robin Lorenz; Lee Freiburger; Daniel Andreas Rutz; Maike Krause; Bettina Karolina Zierer; Sara Alvira; Jorge Cuéllar; José María Valpuesta; Tobias Madl; Michael Sattler; Johannes Buchner
Journal:  Mol Cell       Date:  2014-03-06       Impact factor: 17.970

6.  Localization of sites of interaction between p23 and Hsp90 in solution.

Authors:  Maria A Martinez-Yamout; Rani P Venkitakrishnan; Nicholas E Preece; Gerard Kroon; Peter E Wright; H Jane Dyson
Journal:  J Biol Chem       Date:  2006-03-25       Impact factor: 5.157

7.  Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.

Authors:  M V Blagosklonny; J Toretsky; S Bohen; L Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

8.  Zn(2+)-dependent misfolding of the p53 DNA binding domain.

Authors:  James S Butler; Stewart N Loh
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

9.  Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.

Authors:  James S Butler; Stewart N Loh
Journal:  Biochemistry       Date:  2003-03-04       Impact factor: 3.162

10.  Single-molecule force spectroscopy reveals folding steps associated with hormone binding and activation of the glucocorticoid receptor.

Authors:  Thomas Suren; Daniel Rutz; Patrick Mößmer; Ulrich Merkel; Johannes Buchner; Matthias Rief
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-26       Impact factor: 11.205

View more
  2 in total

Review 1.  Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes.

Authors:  Lev Zavileyskiy; Victoria Bunik
Journal:  Biomolecules       Date:  2022-02-18

Review 2.  P63 and P73 Activation in Cancers with p53 Mutation.

Authors:  Bi-He Cai; Yun-Chien Hsu; Fang-Yu Yeh; Yu-Rou Lin; Rui-Yu Lu; Si-Jie Yu; Jei-Fu Shaw; Ming-Han Wu; Yi-Zhen Tsai; Ying-Chen Lin; Zhi-Yu Bai; Yu-Chen Shih; Yi-Chiang Hsu; Ruo-Yu Liao; Wei-Hsin Kuo; Chao-Tien Hsu; Ching-Feng Lien; Chia-Chi Chen
Journal:  Biomedicines       Date:  2022-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.